Cenegenics Medical Institute is categorized under Health Services in Pittsford, NY and active since 2008.
Cenegenics Medical Institute was established in 2008, and today employs 1 to 4, earning $500.000 to $999.999 per year. This is a Health Services business, which does work in the B2C market, and is classified as a Health Services, under code number 6211110 by the NAICS.
If you are seeking more information, feel free to contact Charles Cavallaro at the company’s single location by writing to 1080 Pittsford Victor Road, Pittsford, New York NY 14534 or by phoning (585) 662-5155. You can also visit this business on Facebook by going to their profile page at Facebook or on find them on Twitter.
| Business Name: | Cenegenics Medical Institute |
| Contact Person: | Charles Cavallaro |
| Address: | 1080 Pittsford Victor Road, Pittsford, New York 14534 |
| Phone Number: | (585) 662-5155 |
| Annual Revenue (USD): | $500.000 to $999.999 |
| Founded: | 2008 |
| Location Type: | Single Location |
| Employee Number: | 1 to 4 |
| Business Type: | B2C (Business to Consumer) |
| Business Category: | Health Services |
| SIC Code: | 8099 |
| NAICS Code: | 6211110 |
| Share This Business: |
Cenegenics Medical Institute was started in 2008 to provide professional Health Services under the SIC code 8099 and NAICS code 6211110. Since its inception, the company has gone on to take a total of 1 to 4 personnel under its employment and has achieved earnings of $500.000 to $999.999 per annum.
Feel free to contact Charles Cavallaro for inquiries that concern Cenegenics Medical Institute by calling the company number (585) 662-5155, as your correspondence is most welcome. Additionally, the physical location of the single location of Cenegenics Medical Institute can be found at the coordinates 43.05089,-77.46989 as well as the street address 1080 Pittsford Victor Road in Pittsford, New York 14534.
For its online presence, you may visit Cenegenics Medical Institute’s website at and engage with its social media outlets through on Twitter and on Facebook.